What is Schizophrenia

Schizophrenia is a chronic, severe, and disabling brain disease, wherein the affected person often suffers terrifying symptoms, such as hearing internal voices not heard by others, or believing that other people are reading their minds, controlling their thoughts, or plotting to harm them. Their speech and behavior can become so disorganized that they may be incomprehensible or appear frightening to others. The symptoms of schizophrenia often make individuals afflicted with the disease to become extremely fearful and withdrawn.

Around 1 percent of the population develops schizophrenia in their lifetime. The disorder affects both men and women equally, though it often appears earlier in men, usually in their late teens or early twenties, than in women, who are mostly affected in their twenties to early thirties. Schizophrenia has long been viewed as an incurable illness, though new data has revealed that as many as 50% of people diagnosed with the disorder witness positive outcomes after receiving appropriate treatment. As new research increases awareness about the causes of schizophrenia, the outlook for individuals afflicted with the disorder continues to improve.

What Causes Schizophrenia

Various neurodevelopmental (impairment of the growth and development of the brain) and neurodegenerative (progressive loss of structure or function of neurons) factors appear to be in play over the course of this illness. A number of studies of people with schizophrenia have found abnormalities in their brain structure, such as reduced volume of the cerebral cortex, lower cerebral blood flow and reduced activation in the frontal regions.

The prefrontal cortex, the part of the frontal lobes lying just behind the forehead, is the key area involved in Executive Functions, which refer to a set of brain-based cognitive skills that help people regulate their thinking, emotions, and behavior. This explains the disordered thought processes and cognitive problems seen in schizophrenics. Studies have shown that when attempting to regulate their emotional responses, individuals with schizophrenia are often unable to activate the brain’s prefrontal regions that are involved in controlling emotions and fail to effectively engage the prefrontal cortex to regulate their behaviour.

Cerebra’s Treatment for Schizophrenia

People with neuropsychological conditions involving the self-regulation of cortical activity, like schizophrenia, can benefit vastly by the use of Cerebra TurboBrain (CTB) technology, since most of their issues are centered around a poorly functioning PFC, and that is what Cerebra targets. CTB’s outstanding technology resolves poor blood flow, reduced volume and development issues by increasing Cerebral Blood Flow into the Pre-frontal cortex. CTB’s cerebral blood flow measuring technology, in which a specially designed sensor sends brain readings to the computer in real time, enables the individual to control the on-screen activity by the mind alone, thus, enhancing cognitive abilities, emotional control and self regulation.

By increasing cerebral blood flow, CTB increases the rate of capillary formation – Angiogenesis – and improves extensive synaptic connections among neurons through the process of Synaptogenesis – thereby drastically improving thinking, memory, focus and attention. Completely safe, drug-free, and used by thousands of people in the US for over a decade now, CTB is now also being used in India, including Mumbai and New Delhi.

Cerebra’s suite of brain enhancement and regeneration technologies also includes Cerebra PhotoBioStim (CPBS) that uses coherent light to directly stimulate affected areas in the brain all over the scalp and is transforming the lives of Autistic, hyperactive and mentally retarded children across Asia, including Mumbai and New Delhi.

Both CPBS and CTB offer great potential in the resolution of adult disorders, such as stroke, traumatic brain injury, depression, schizophrenia, Alzheimer’s, dementia, etc., and are already delivering promising results for affected people across Asia, including Mumbai and New Delhi.

Please visit the Scientific Research section in the website to read about the vast amount of studies that is being done on CPBS and CTB technologies.

Why Early Intervention Is Important In Treatment for Schizophrenia

Unless proper treatment is given, some individuals affected by schizophrenia become so psychotic and disorganized that they are no longer able to take care of even their basic needs, like food, clothing, and shelter. Intervening aggressively at an early stage is crucial in all neurological diseases, as the brain’s abilities declines sharply with each passing day. So, the earlier the intervention, the better the chances of arresting the decline in mental skills, which, once lost completely, may be almost impossible to regain.

Schizophrenia is a life-changing event that affects not only the patients themselves, but also their family members and caregivers. Early intervention is vital in order to improve the patient’s cognitive functions and quality of life, as well as reduce the caregiver’s burden. Timely treatment with CPBS and CTB training before the patient becomes completely psychotic and disorganized can slow or even stop the progression of symptoms.

Please visit the Success Stories section in the website to read heart-warming testimonials of the remarkable benefits being experienced by individuals suffering from Schizophrenia who are undergoing CTB and CPBS training.